Eamon Javers, a CNBC journalist, brings insight into President-elect Trump's economic strategies. The hosts discuss market shifts after record highs, as well as Trump's tariff threats and his economic team choices. Dell's disappointing revenue and the resulting stock decline highlight challenges in tech. They also explore SoftBank's hefty investment in OpenAI and the implications for health innovations in weight-loss drugs. The conversation wraps up with consumer behavior trends and their surprising effects on stock performance.

Listen as financial experts discuss the dynamic retail landscape and the performances of companies like Best Buy. They delve into the impact of healthcare coverage on the pharmaceutical sector, shedding light on Amgen's trajectory. The conversation also examines the contrasting fortunes within the semiconductor industry. Perfect for investors looking to navigate upcoming market challenges!

The discussion kicks off with the mixed performance of stock indices and crucial corporate news as the holiday season approaches. Economic indicators reveal rising consumer confidence but falling home sales, amidst tariffs affecting trade relationships. Retail trends come under the spotlight as companies face unique challenges, particularly in the apparel sector. The volatile Bitcoin market is examined alongside weight loss drug developments and their future in Medicare. Corporate policy shifts at Walmart highlight the push for changes in diversity and inclusion due to activist pressures.

The discussion kicks off with President-elect Trump's tariff threats, stirring concerns in various market sectors. With Black Friday approaching, earnings from retailers like Best Buy are analyzed for holiday quarter insights. Amgen faces a stock slide due to disappointing results from its weight-loss drug trials. The hosts delve into Bitcoin's recent downturn and examine the innovative AI sounds being pioneered by Nvidia. Tensions heat up with a look at the geopolitical landscape affecting major oil players like Chevron and Exxon.

Jim and Jeff dive into the biopharmaceutical landscape, spotlighting Bristol-Myers' groundbreaking schizophrenia drug and its investment implications. They also discuss the looming patent cliffs that could reshape earnings forecasts by 2028. The conversation veers into the financial outlook for major players like Bristol-Myers and Eli Lilly, exploring revenue potential linked to new drug approvals amidst the challenges of product development. It's an insightful take on the pharmaceutical market dynamics and investment strategies.

Brian Belsky, Chief Investment Strategist at BMO Capital Markets, shares his insights on market dynamics as the S&P and Dow reach new heights. He highlights financials, tech, and discretionary sectors as key players for growth. The discussion also covers Trump's pick for Treasury Secretary, Scott Bessant, and its potential market influence. Legal challenges facing Google over advertising practices are examined, alongside the bullish case for a year-end market rally and an optimistic outlook for tech stocks.

A historic day for stocks as the Dow and S&P 500 hit record highs following Scott Bessent's Treasury appointment! The discussion covers potential policies like tax cuts and tariffs under Trump. Warren Buffett’s impressive $1.1 billion donation also steals the spotlight. Retail outlooks are mixed as Thanksgiving approaches. Tech giants face new challenges with AI and competition. A dive into market strategies reveals shifting sentiments, especially among younger investors attracted to high-risk assets. Plus, insights on college sports recruitment and corporate dynamics add a playful twist!

Stocks have been on a winning streak, despite some bumps in major tech names. Investors are re-strategizing as the Trump administration approaches. Bitcoin is making headlines, inching closer to that $100K milestone. Meanwhile, IMAX CEO shares insights on a blockbuster weekend with 'Wicked' and 'Gladiator II' hitting theaters. The film industry seems poised for a major comeback, reflecting a shift in consumer habits and a return to the big screen.

The conversation dives into the hunt for the next big tech stock like Nvidia, with sage advice on what to look for. Political dynamics heat up with talk of a new Treasury Secretary in the making and how tariffs could impact retail. Stocks from Gap to Ross surge on positive earnings and holiday outlooks. Meanwhile, Amazon's bold $4 billion investment in Anthropic raises eyebrows, and the tech duel between OpenAI and Google captivates attention. Plus, a quirky look at dueling magazine covers featuring Elon Musk adds some flair to the mix.

Jim and Jeff break down the market reaction to this chipmaker’s earnings. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer